glp-1 adoption The trend: What the real-world data reveals GLP-1 adoption forces CPGs to

Branching off the above point, avoid brands that promise magic pill resultsthese are usually a red flag

Its important to understand both the benefits and the risks associated with these medications

Prior serious hypersensitivity to semaglutide is a contraindication to Wegovy, and prior serious hypersensitivity to tirzepatide is a contraindication to Zepbound

This one nutrient consistently stands out in the research

L., Oriana, H

Consumers may think theyre getting a blockbuster GLP-1 drug like semaglutide the active ingredient in Ozempic and Wegovy or tirzepatide the active ingredient in Mounjaro and Zepbound in a format thats applied to the skin